Literature DB >> 16247015

Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1.

Edward Htun van der Horst1, Yan Y Degenhardt, Astrid Strelow, Anthony Slavin, Lawrence Chinn, Jessica Orf, Minqing Rong, Shyun Li, Lei-Hoon See, Ken Q C Nguyen, Timothy Hoey, Holger Wesche, Scott Powers.   

Abstract

Metastasis of primary tumors leads to a very poor prognosis for patients suffering from cancer. Although it is well established that not every tumor will eventually metastasize, it is less clear whether primary tumors acquire genetic alterations in a stochastic process at a late stage, which make them invasive, or whether genetic alterations acquired early in the process of tumor development drive primary tumor growth and determine whether this tumor is going to be metastatic. To address this issue, we tested genes identified in a large-scale comparative genomic hybridization analysis of primary tumor for their ability to confer metastatic properties on a cancer cell. We identified amplification of the ACK1 gene in primary tumors, which correlates with poor prognosis. We further show that overexpression of Ack1 in cancer cell lines can increase the invasive phenotype of these cells both in vitro and in vivo and leads to increased mortality in a mouse model of metastasis. Biochemical studies show that Ack1 is involved in extracellular matrix-induced integrin signaling, ultimately activating signaling processes like the activation of the small GTPase Rac. Taken together, this study supports a theory from Bernards and Weinberg [Bernards, R. & Weinberg, R. A. (2002) Nature 418, 823], which postulates that the tendency to metastasize is largely predetermined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247015      PMCID: PMC1276100          DOI: 10.1073/pnas.0508014102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

Review 2.  Tumor progression: Small GTPases and loss of cell-cell adhesion.

Authors:  Encarnación Lozano; Martha Betson; Vania M M Braga
Journal:  Bioessays       Date:  2003-05       Impact factor: 4.345

3.  Genomic analyses of primary and metastatic serous epithelial ovarian cancer.

Authors:  Ofir Israeli; Walter H Gotlieb; Eitan Friedman; Jacob Korach; Eddy Friedman; Boleslaw Goldman; Assaf Zeltzer; Assaf Zeltser; Gilad Ben-Baruch; Shlomit Rienstein; Ayala Aviram-Goldring
Journal:  Cancer Genet Cytogenet       Date:  2004-10-01

Review 4.  Compilation of published comparative genomic hybridization studies.

Authors:  Stéphanie Struski; Martine Doco-Fenzy; Pascale Cornillet-Lefebvre
Journal:  Cancer Genet Cytogenet       Date:  2002-05

5.  Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

Authors:  Jing Yang; Sendurai A Mani; Joana Liu Donaher; Sridhar Ramaswamy; Raphael A Itzykson; Christophe Come; Pierre Savagner; Inna Gitelman; Andrea Richardson; Robert A Weinberg
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

6.  Genetic evaluation of localized prostate cancer in a cohort of forty patients: gain of distal 8q discriminates between progressors and nonprogressors.

Authors:  Herman van Dekken; Janneke C Alers; Irma A A J Damen; Kees J Vissers; Pieter-Jaap Krijtenburg; Robert F Hoedemaeker; Mark F Wildhagen; Wim C J Hop; Theodorus H van der Kwast; Hans J Tanke; Fritz H Schröder
Journal:  Lab Invest       Date:  2003-06       Impact factor: 5.662

7.  In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.

Authors:  Emiel A M Janssen; Jan P A Baak; Marta Alonso Guervós; Paul J van Diest; M Jiwa; Mario A J A Hermsen
Journal:  J Pathol       Date:  2003-12       Impact factor: 7.996

8.  Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis.

Authors:  Hui Wang; Weili Fu; Jae Hong Im; Zengyi Zhou; Samuel A Santoro; Vandana Iyer; C Mike DiPersio; Qian-Chun Yu; Vito Quaranta; Abu Al-Mehdi; Ruth J Muschel
Journal:  J Cell Biol       Date:  2004-03-15       Impact factor: 10.539

9.  Expression profiling predicts outcome in breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; René Bernards; Stephen H Friend
Journal:  Breast Cancer Res       Date:  2002-12-04       Impact factor: 6.466

10.  Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation?

Authors:  H S Patmore; J N E Ashman; L Cawkwell; A MacDonald; N D Stafford; J Greenman; N E Ashman James
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

View more
  63 in total

1.  Bayesian Weibull tree models for survival analysis of clinico-genomic data.

Authors:  Jennifer Clarke; Mike West
Journal:  Stat Methodol       Date:  2008

2.  Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells.

Authors:  Boon Tin Chua; Shu Jing Lim; Su Chin Tham; Wei Jie Poh; Axel Ullrich
Journal:  Mol Oncol       Date:  2010-03-19       Impact factor: 6.603

3.  Molecular pathways: targeting the kinase effectors of RHO-family GTPases.

Authors:  Tatiana Y Prudnikova; Sonali J Rawat; Jonathan Chernoff
Journal:  Clin Cancer Res       Date:  2014-10-21       Impact factor: 12.531

4.  Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2.

Authors:  Wing Chan; Rui Tian; Yeow-Fong Lee; Soon Tuck Sit; Louis Lim; Ed Manser
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

5.  HECT E3 ubiquitin ligase Nedd4-1 ubiquitinates ACK and regulates epidermal growth factor (EGF)-induced degradation of EGF receptor and ACK.

Authors:  Qiong Lin; Jian Wang; Chandra Childress; Marius Sudol; David J Carey; Wannian Yang
Journal:  Mol Cell Biol       Date:  2010-01-19       Impact factor: 4.272

Review 6.  Palindromic gene amplification--an evolutionarily conserved role for DNA inverted repeats in the genome.

Authors:  Hisashi Tanaka; Meng-Chao Yao
Journal:  Nat Rev Cancer       Date:  2009-02-12       Impact factor: 60.716

7.  Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.

Authors:  Y Liu; M Karaca; Z Zhang; D Gioeli; H S Earp; Y E Whang
Journal:  Oncogene       Date:  2010-04-12       Impact factor: 9.867

8.  Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation.

Authors:  Kiran Mahajan; Domenico Coppola; Sridevi Challa; Bin Fang; Y Ann Chen; Weiwei Zhu; Alexis S Lopez; John Koomen; Robert W Engelman; Charlene Rivera; Rebecca S Muraoka-Cook; Jin Q Cheng; Ernst Schönbrunn; Said M Sebti; H Shelton Earp; Nupam P Mahajan
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

9.  A chemical and phosphoproteomic characterization of dasatinib action in lung cancer.

Authors:  Jiannong Li; Uwe Rix; Bin Fang; Yun Bai; Arthur Edwards; Jacques Colinge; Keiryn L Bennett; Jingchun Gao; Lanxi Song; Steven Eschrich; Giulio Superti-Furga; John Koomen; Eric B Haura
Journal:  Nat Chem Biol       Date:  2010-02-28       Impact factor: 15.040

Review 10.  Endocytosis and cancer.

Authors:  Ira Mellman; Yosef Yarden
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.